Page last updated: 2024-09-04
centa and avibactam
centa has been researched along with avibactam in 1 studies
Compound Research Comparison
| Studies (centa) | Trials (centa) | Recent Studies (post-2010) (centa) | Studies (avibactam) | Trials (avibactam) | Recent Studies (post-2010) (avibactam) |
|---|---|---|---|---|---|
| 8 | 0 | 4 | 360 | 16 | 352 |
Protein Interaction Comparison
| Protein | Taxonomy | centa (IC50) | avibactam (IC50) |
|---|---|---|---|
| Beta-lactamase | Enterobacter cloacae | 0.1 | |
| Beta-lactamase | Pseudomonas aeruginosa PAO1 | 0.128 | |
| Beta-lactamase TEM | Escherichia coli | 0.0019 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bayer, A; Christopeit, T; Guttormsen, Y; Leiros, HK; Lund, BA | 1 |
Other Studies
1 other study(ies) available for centa and avibactam
| Article | Year |
|---|---|
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Surface Plasmon Resonance | 2016 |